# Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung

> **NCT01225965** · NA · COMPLETED · sponsor: **Bitop AG** · enrollment: 36 (actual)

## Conditions studied

- COPD
- Particulate Matter Induced Inflammation of the Lung

## Interventions

- **DEVICE:** Ectoin Inhalation Solution
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT01225965
- **Lead sponsor:** Bitop AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-02
- **Final completion:** 2011-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01225965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01225965, "Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01225965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*